Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mulberry Twig Alkaloid Tablet vs Canagliflozin in T2DM
NCT05856578Phase 4Unknown
- Sponsor
- Nanjing First Hospital
- Start
- Mar 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ramulus mori alkaloids in type 2 diabetes mellitus (T2DM), sponsored by Nanjing First Hospital. Status: unknown.
02
Drugs
ramulus mori alkaloids
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05856578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05856578.